Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.
Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, New York, New York, United States of America.
PLoS One. 2019 Aug 12;14(8):e0220717. doi: 10.1371/journal.pone.0220717. eCollection 2019.
Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) and the nuclear receptor co-repressor1 (NCoR1) are paralogs and regulate nuclear receptor (NR) function through the recruitment of a multiprotein complex that includes histone deacetylase activity. Previous genetic strategies which deleted SMRT in a specific tissue or which altered the interaction between SMRT and NRs have suggested that it may regulate adiposity and insulin sensitivity. However, the full role of SMRT in adult mice has been difficult to establish because its complete deletion during embryogenesis is lethal. To elucidate the specific roles of SMRT in mouse target tissues especially in the context of thyroid hormone (TH) signaling, we used a tamoxifen-inducible post-natal disruption strategy. We found that global SMRT deletion causes dramatic obesity even though mice were fed a standard chow diet and exhibited normal food intake. This weight gain was associated with a decrease in energy expenditure. Interestingly, the deletion of SMRT had no effect on TH action in any tissue but did regulate retinoic acid receptor (RAR) function in the liver. We also demonstrate that the deletion of SMRT leads to profound hepatic steatosis in the setting of obesity. This is unlike NCoR1 deletion, which results in hepatic steatosis due to the upregulation of lipogenic gene expression. Taken together, our data demonstrate that SMRT plays a unique and CoR specific role in the regulation of body weight and has no role in TH action. This raises the possibility that additional role of CoRs besides NCoR1 and SMRT may exist to regulate TH action.
沉默调节蛋白和甲状腺激素受体 (SMRT) 和核受体共抑制因子 1 (NCoR1) 是同源物,通过招募包括组蛋白去乙酰化酶活性的多蛋白复合物来调节核受体 (NR) 的功能。以前的遗传策略,即在特定组织中删除 SMRT 或改变 SMRT 与 NR 之间的相互作用,表明它可能调节脂肪含量和胰岛素敏感性。然而,由于胚胎发生过程中 SMRT 的完全缺失是致命的,因此很难确定 SMRT 在成年小鼠中的全部作用。为了阐明 SMRT 在小鼠靶组织中的特定作用,特别是在甲状腺激素 (TH) 信号转导的背景下,我们使用了一种他莫昔芬诱导的产后破坏策略。我们发现,尽管小鼠喂食标准饲料且食物摄入量正常,但全球 SMRT 缺失会导致明显的肥胖。这种体重增加与能量消耗减少有关。有趣的是,SMRT 的缺失对任何组织中的 TH 作用都没有影响,但确实调节了肝脏中的视黄酸受体 (RAR) 功能。我们还证明,SMRT 的缺失会导致肥胖小鼠肝脏出现严重的脂肪变性。这与 NCoR1 的缺失不同,后者导致肝脏脂肪变性是由于脂肪生成基因表达的上调。总之,我们的数据表明 SMRT 在调节体重方面发挥着独特的、特异性的 CoR 作用,并且在 TH 作用中没有作用。这表明除了 NCoR1 和 SMRT 之外,CoR 可能还有其他调节 TH 作用的作用。